Our vision and strategy

Industry Outlook
• Cultivation becoming a commodity
• Value added products substituting flowers
• Growing emphasis on proven medical efficacy
• Opening of international markets
• New entrants from pharma and FMCG

Key success factors
• Low cost and scale
• Product innovation
• R&D and intellectual property
• Exports and multi-domestic supply chains
• Branding

Folium strategy
• Downstream focus with limited in-house grow, and ability to source flower at 0.10$/gr vs Canada 2.00$
• Strong product pipeline supported by strategic innovation alliances
• Medical IP sourced from US, Canada and Israeli R&D providers
• Local distribution offices in key markets
• Adult use brands exposed to 40 M Las Vegas tourists